MARKET WIRE NEWS

Quince Therapeutics Inc. (NASDAQ : QNCX ) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.


Description


Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States.


Quote


Last:$0.1253
Change Percent: -41.2%
Open:$0.1258
Close:$0.2131
High:$0.1589
Low:$0.1202
Volume:133,787,629
Last Trade Date Time:04/09/2026 12:45:58 pm

Stock Data


Market Cap:$29,383,122
Float:44,378,148
Insiders Ownership:0.16%
Institutions:25
Short Percent:N/A
Industry:Biotechnology & Life Sciences
Sector:Healthcare
Website:https://www.quincetx.com
Country:US
City:South San Francisco

Recent News Releases


Subscribe to Our Newsletter


Message Board Posts


investorshub : Doubledown75
investorshub : Doubledown75
investorshub : Doubledown75
investorshub : INV4

**MWN-AI FAQ is based on asking OpenAI questions about Quince Therapeutics Inc. (NASDAQ: QNCX).

Link Market Wire News to Your X Account

Download The Market Wire News App